Rhabdomyolysis connected with the use of bupropion: A possible complication of medical treatment for smoking cessation

Scandinavian Journal of Primary Health Care

Volumn 22, Issue 3, 2004, Pages 191-192

  Bobé, Francesc ^a   Buil, Maria Eugenia ^a   Palacios, Laura ^a  

^a INSTITUT CATALÀ DE LA SALUT   (Spain)

Author keywords

Bupropion; Primary health care; Rhabdomyolysis; Smoking cessation

Indexed keywords

AMFEBUTAMONE;

ADULT; ANAPHYLAXIS; ANXIETY; ARTICLE; CASE REPORT; HEADACHE; HUMAN; INSOMNIA; MALE; MYALGIA; NAUSEA; PRIMARY HEALTH CARE; RHABDOMYOLYSIS; SEIZURE; SIDE EFFECT; SLOW DRUG RELEASE; SMOKING CESSATION; XEROSTOMIA;

ADULT; BUPROPION; HUMANS; MALE; RHABDOMYOLYSIS; SMOKING; SMOKING CESSATION;

EID: 4644369371     PISSN: 02813432     EISSN: None     Source Type: Journal    
DOI: 10.1080/02813430310000979     Document Type: Article

References (6)

1. Mallin R. Smoking cessation: integration of behavioural and drug therapies. Am Fam Physician 2002;65:1107-14.
2. Jorenby D. Clinical efficacy of bupropion in the management of smoking cessation. Drugs 2002;62(Suppl 2):25-35.
3. West R. Bupropion SR for smoking cessation. Expert Opin Pharmacother 2003;4:533-40.
4. Aubin HJ. Tolerability and safety of sustained-release bupropion in the management of smoking cessation. Drugs 2002;62(Suppl 2):45-52.
5. Sauret JM, Marinides G, Wang GK. Rhabdomyolysis. Am Fam Physician 2002;65:907-12.
6. David D, Esquenazi J. Rhabdomyolysis associated with bupropion treatment. J Clin Psychopharmacol 1999;19:185-6.